Re grants:
Prima BioMed (ASX: PRR) has shared in a EUR 4.1 million (A$5.35 million) grant with the Fraunhofer Institute of Cell Therapy and Immunology (Fraunhofer IZI) to support the upcoming clinical trial of CVac™ in ovarian cancer.
I can't recall what the Aussie grants are worth, however they are not carried on the balance sheet as they must be drawn down in arrears.
Re Springtree
Their strategy was to be issued shares from the company each month and sell them back into the market immediately, to recycle their capital. I'm pretty sure they haven't held any shares for the past year.
You'll also find that the comment about cash on hand was "as at the last quarterly report" which is the norm for such announcements.
cannot work traders out..., page-91
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $1.317M | 3.935M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73996 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 836970 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |